| 000 | 01898 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516103415.0 | ||
| 264 | 0 | _c20130226 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a2211-1247 | ||
| 024 | 7 |
_a10.1016/j.celrep.2011.12.002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHammachi, Fella | |
| 245 | 0 | 0 |
_aTranscriptional activation by Oct4 is sufficient for the maintenance and induction of pluripotency. _h[electronic resource] |
| 260 |
_bCell reports _cFeb 2012 |
||
| 300 |
_a99-109 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aDNA _xmetabolism |
| 650 | 0 | 4 |
_aEmbryonic Stem Cells _xcytology |
| 650 | 0 | 4 |
_aGene Expression Regulation, Developmental _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xcytology |
| 650 | 0 | 4 |
_aLeukemia Inhibitory Factor _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aOctamer Transcription Factor-3 _xmetabolism |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xmetabolism |
| 650 | 0 | 4 |
_aRepressor Proteins _xmetabolism |
| 650 | 0 | 4 |
_aTranscriptional Activation _xdrug effects |
| 650 | 0 | 4 | _aXenopus |
| 700 | 1 | _aMorrison, Gillian M | |
| 700 | 1 | _aSharov, Alexei A | |
| 700 | 1 | _aLivigni, Alessandra | |
| 700 | 1 | _aNarayan, Santosh | |
| 700 | 1 | _aPapapetrou, Eirini P | |
| 700 | 1 | _aO'Malley, James | |
| 700 | 1 | _aKaji, Keisuke | |
| 700 | 1 | _aKo, Minoru S H | |
| 700 | 1 | _aPtashne, Mark | |
| 700 | 1 | _aBrickman, Joshua M | |
| 773 | 0 |
_tCell reports _gvol. 1 _gno. 2 _gp. 99-109 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.celrep.2011.12.002 _zAvailable from publisher's website |
| 999 |
_c21974553 _d21974553 |
||